News & events

Study gets under way to test psilocybin for treatment-resistant depression

The NIHR-Wellcome Trust King's Clinical Research Facility has administered psilocybin to a patient with treatment-resistant depression in the first randomised controlled trial of its kind.

By Administrator at 17 Sep 2019

Six BRC academics promoted to new positions, including two new professorships

The BRC is delighted to announce that six of its researchers have been promoted, with their new academic positions coming into effect this month.

By Administrator at 10 Sep 2019

Inspiring the next generation: budding young scientists go behind the scenes at the BRC

This year’s winners of our BRC Youth Awards, part of the IoPPN Youth Awards, have completed two days of work experience with leading clinicians, scientists and researchers at our Denmark Hill campus.

By Administrator at 28 Aug 2019

Close monitoring essential to ensure safety of ketamine for depression

Patients, carers and advocates say better evidence is needed on the safety of ketamine for depression after long-term use, and that those prescribed it must be closely monitored. These are the results of a study undertaken as part of a collaboration between the NIHR Maudsley Biomedical Research Centre (BRC) and NIHR Oxford Health Biomedical Research Centre (BRC). 

 

By Administrator at 30 Jul 2019

Compensatory strategies to disguise autism spectrum disorder may delay diagnosis and have negative consequences for mental health

For the first time, compensatory strategies used by autistic adults have been investigated and collated in a qualitative study by BRC researcher, Professor Francesca Happé, and her MRC-funded PhD student, Lucy Livingston, published today in The Lancet Psychiatry journal.

By NIHR Maudsley BRC at 24 Jul 2019